Symbiomix Therapeutics Company
Symbiomix Therapeutics is a privately-held biopharmaceutical company that offers anti-infective drug and single dose treatment.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Newark, New Jersey, United States
Founded Date:
2012
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
5
Total Funding:
$47 000 000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018-01-01
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership